ArticleFrontiers in cardiovascular medicine2026
Segmental analysis of left atrial substrate severity predictors in patients undergoing persistent atrial fibrillation ablation.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Outcomes after catheter ablation remain suboptimal in persistent atrial fibrillation (AF), likely reflecting a more pronounced left atrial (LA) structural and electrical remodeling in these patients. Empirical additional ablation lesions lack robust supporting evidence and may even lead to adverse outcomes, underlining the need to tailor ablation procedures to the individual atrial substrate. The objective of the study was to perform a multidimensional and segment-by-segment assessment of LA substrate anomalies in persistent AF. Methods: In this single-center retrospective study, 69 consecutive patients undergoing ablation for drug-refractory persistent AF were analyzed. Four factors were selected as possible predictors of LA substrate severity: bipolar voltage, left atrial wall thickness (LAWT), epicardial adipose tissue (EAT) and AF drivers. An AI-based platform was used to segment the LA and to provide detailed analyses. Results: Among the selected predictors several correlations were identified. Median follow-up duration was 845 days; freedom from recurrence at 12 months was 70.6%. At survival analysis, higher mean percentage of very low-voltage zones (<0.2 mV) predicted recurrences (HR 1.025; Discussion: The intricate relationship between structural and electrical remodeling in persistent AF underscores the critical role of LA substrate characterization. Understanding the correlations among factors that may indicate atrial substrate abnormalities, including through AI-based platforms, may help deliver a more personalized procedure for each patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.